{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:57:19Z","timestamp":1792007839120,"version":"4.4.0"},"publisher-location":"Chichester, UK","reference-count":132,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006612.pub2","type":"reference-entry","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T14:38:38Z","timestamp":1256135918000},"source":"Crossref","is-referenced-by-count":58,"title":["Homocysteine lowering interventions for preventing cardiovascular events"],"prefix":"10.1002","author":[{"given":"Arturo J","family":"Mart\u00ed-Carvajal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Sol\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Lathyris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Salanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,10,7]]},"reference":[{"issue":"Suppl II","key":"10.1002\/14651858.CD006612.pub2-BIB1|cit1","first-page":"741","article-title":"Blinded comparison of folic acid and placebo in patients with ischaemic heart disease: an outcome trial","volume":"106","author":"Baker","year":"2002","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD006612.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2003.02.001","article-title":"Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial","volume":"93","author":"Liem","year":"2004","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0735-1097(03)00485-6","article-title":"Secondary prevention with folic acid: effects on clinical outcomes","volume":"41","author":"Liem","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/hrt.2004.035030","article-title":"Secondary prevention with folic acid: results of the Goes extension study","volume":"91","author":"Liem","year":"2005","journal-title":"Heart"},{"key":"10.1002\/14651858.CD006612.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006612.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006612.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/01.STR.0000185929.38534.f3","article-title":"Vitamin Intervention For Stroke Prevention trial: an efficacy analysis","volume":"36","author":"Spence","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD006612.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","article-title":"Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial","volume":"299","author":"Albert","year":"2008","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD006612.pub2-BIB10|cit10","first-page":"52","article-title":"A randomized trial of folic acid and B-vitamins in the secondary prevention of cardiovascular events in women: Results from the Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)","volume":"16","author":"Redbeg","year":"2006","journal-title":"ACC Cardiosource Review Journal."},{"key":"10.1002\/14651858.CD006612.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial","volume":"300","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.296.22.2720","article-title":"Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"296","author":"Bazzano","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub2-BIB13|cit13","unstructured":"Nevado J Folate Intervention in Non-ST elevation myocardial infarction and unstable angina: a randomised placebo-controlled trial http:\/\/controlled-trials.com\/ISRCTN30249553\/homocysteine (accessed Oct 12th 2007)"},{"key":"10.1002\/14651858.CD006612.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1056\/NEJMoa032845","article-title":"Folate therapy and in-stent restenosis after coronary stenting","volume":"350","author":"Lange","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006612.pub2-BIB15|cit15","first-page":"481","article-title":"Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction?","volume":"14","author":"Lonn","year":"2007","journal-title":"Current Opinion in Hematology ."},{"key":"10.1002\/14651858.CD006612.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1053\/euhj.2002.3161","article-title":"Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease","volume":"23","author":"Neal","year":"2002","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD006612.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.288.8.973","article-title":"Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial","volume":"288","author":"Schnyder","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1957-2557(07)91997-5","article-title":"Efficacy of folic acid in prevention of cerebrovascular disease","volume":"1","author":"Vesin","year":"2007","journal-title":"Medecine des Maladies Metaboliques"},{"key":"10.1002\/14651858.CD006612.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0140-6736(07)60854-X","article-title":"Efficacy of folic acid supplementation in stroke prevention: a meta-analysis","volume":"369","author":"Wang","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006612.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3132\/dvdr.2007.033","article-title":"Homocysteine and cardiovascular disease: a review of the evidence","volume":"4","author":"Wierzbicki","year":"2007","journal-title":"Diabetes & Vascular Disease Research"},{"key":"10.1002\/14651858.CD006612.pub2-BIB21|cit21","first-page":"195","article-title":"A pilot study with simvastatin and folic acid\/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)","volume":"10","author":"MacMahon","year":"2000","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases"},{"key":"10.1002\/14651858.CD006612.pub2-BIB22|cit22","first-page":"428","article-title":"Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and\/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries","volume":"7","author":"Galan","year":"2003","journal-title":"The Journal of Nutrition, Health & Aging"},{"key":"10.1002\/14651858.CD006612.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000047761","article-title":"The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke","volume":"13","year":"2002","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD006612.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.arcmed.2007.01.004","article-title":"Acute hyperhomocysteinemia induces microvascular and macrovascular endothelial dysfunction","volume":"38","author":"Abahji","year":"2007","journal-title":"Archives of Medical Research"},{"key":"10.1002\/14651858.CD006612.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.amjmed.2003.10.024","article-title":"Effect of folic acid fortification of food on homocysteine-related mortality","volume":"116","author":"Anderson","year":"2004","journal-title":"American Journal of Medicine."},{"issue":"3","key":"10.1002\/14651858.CD006612.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1503\/cmaj.1031155","article-title":"Vitamin B12 (cobalamin) deficiency in elderly patients","volume":"171","author":"Andr\u00e8s","year":"2004","journal-title":"CMAJ : Canadian Medical Association journal = journal de l'Association Medicale Canadienne"},{"key":"10.1002\/14651858.CD006612.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ahj.2005.04.025","article-title":"Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials","volume":"151","year":"2006","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD006612.pub2-BIB28|cit28","first-page":"392","article-title":"Protein homocysteinylation: a new mechanism of atherogenesis?","volume":"59","author":"Be\u0142towski","year":"2005","journal-title":"Post\u0119py higieny i medycyny do\u015bwiadczalnej"},{"key":"10.1002\/14651858.CD006612.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2796.2007.01810.x","article-title":"Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease","volume":"262","author":"Bleie","year":"2007","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD006612.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(05)70152-5","article-title":"Homocysteine and stroke: evidence on a causal link from mendelian randomisation","volume":"365","author":"Casas","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006612.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10545-006-0106-5","article-title":"Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview","volume":"29","author":"Castro","year":"2006","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1002\/14651858.CD006612.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MCO.0b013e328011aa71","article-title":"Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia","volume":"10","author":"Clarke","year":"2007","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1002\/14651858.CD006612.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1001\/jama.297.21.2351","article-title":"Folic acid for the prevention of colorectal adenomas: a randomized clinical trial","volume":"297","author":"Cole","year":"2007","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00043798-199808000-00004","article-title":"Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies","volume":"5","author":"Danesh","year":"1998","journal-title":"Journal of Cardiovascular Risk"},{"key":"10.1002\/14651858.CD006612.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Davey Smith","year":"2003","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1573401052953221","article-title":"Let them eat cake","volume":"1","author":"Durga","year":"2005","journal-title":"Current Nutrition & Food Science"},{"key":"10.1002\/14651858.CD006612.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.STR.0000150494.91762.70","article-title":"Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial","volume":"36","author":"Dusitanond","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD006612.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","article-title":"Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence","volume":"131","author":"Eikelboom","year":"1999","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD006612.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.CIR.93.9.1755","article-title":"Cardiovascular disease epidemiology : a journey from the past into the future","volume":"93","author":"Epstein","year":"1996","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD006612.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2005.08.008","article-title":"Structural modifications of HDL and functional consequences","volume":"184","author":"Ferretti","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD006612.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.98.3.204","article-title":"Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study","volume":"98","author":"Folsom","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD006612.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ije\/31.1.59","article-title":"Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies","volume":"31","author":"Ford","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2005-872394","article-title":"Homocysteine: overview of biochemistry, molecular biology, and role in disease processes","volume":"5","author":"Fowler","year":"2005","journal-title":"Seminars in Vascular Medicine"},{"key":"10.1002\/14651858.CD006612.pub2-BIB45|cit45","article-title":"Cardiovascular Disease","volume-title":"Disease control priorities in developing countries","author":"Gaziano","year":"2006"},{"key":"10.1002\/14651858.CD006612.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1515\/CCLM.2007.347","article-title":"Association between homocysteine, vitamin B(6) concentrations and inflammation","volume":"45","author":"Gori","year":"2007","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"10.1002\/14651858.CD006612.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0369-8114(03)00105-6","article-title":"Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease? 2. Epidemiological data","volume":"51","author":"Guilland","year":"2003","journal-title":"Pathologie-Biologie"},{"key":"10.1002\/14651858.CD006612.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11883-006-0046-4","article-title":"Homocysteine: role and implications in atherosclerosis","volume":"8","author":"Guthikonda","year":"2006","journal-title":"Current Atherosclerosis Reports"},{"key":"10.1002\/14651858.CD006612.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jama.290.7.932","article-title":"Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence","volume":"290","author":"Hackam","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006612.pub2-BIB51|cit51","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD006612.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajcn\/82.4.806","article-title":"Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials","volume":"82","year":"2005","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD006612.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ajcn\/86.5.1405","article-title":"Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in healthy adults","volume":"86","author":"Hoey","year":"2007","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD006612.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4065\/83.11.1203","article-title":"Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis","volume":"83","author":"Humphrey","year":"2008","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD006612.pub2-BIB57|cit57","volume-title":"Code of Federal Regulations & International Conference on Harmonisation Guidelines","year":"1997"},{"key":"10.1002\/14651858.CD006612.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1515\/CCLM.2005.188","article-title":"Molecular targeting by homocysteine: a mechanism for vascular pathogenesis","volume":"43","author":"Jacobsen","year":"2005","journal-title":"Clinical Chemistry & Laboratory Medicine"},{"key":"10.1002\/14651858.CD006612.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.ki.5000235","article-title":"Homocysteine targeting of plasma proteins in hemodialysis patients","volume":"69","author":"Jacobsen","year":"2006","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD006612.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM199905133401901","article-title":"The effect of folic acid fortification on plasma folate and total homocysteine concentrations","volume":"340","author":"Jacques","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"2S Suppl","key":"10.1002\/14651858.CD006612.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"377S","DOI":"10.1093\/jn\/130.2.377S","article-title":"Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans","volume":"130","author":"Jakubowski","year":"2000","journal-title":"Journal of Nutrition"},{"key":"10.1002\/14651858.CD006612.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00018-003-3204-7","article-title":"Molecular basis of homocysteine toxicity in humans","volume":"61","author":"Jakubowski","year":"2004","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1002\/14651858.CD006612.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1515\/CCLM.2005.177","article-title":"Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease","volume":"43","author":"Jakubowski","year":"2005","journal-title":"Clinical Chemistry & Laboratory Medicine"},{"key":"10.1002\/14651858.CD006612.pub2-BIB64|cit64","first-page":"155","article-title":"The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease","volume":"59 (Suppl 9)","author":"Jakubowski","year":"2008","journal-title":"Journal of Physiology and Pharmacology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1096\/fj.08-127548","article-title":"Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice","volume":"23","author":"Jakubowski","year":"2009","journal-title":"The Faseb Journal"},{"key":"10.1002\/14651858.CD006612.pub2-BIB66|cit66","doi-asserted-by":"crossref","DOI":"10.1596\/978-0-8213-6260-0","volume-title":"Priorities in health","author":"Jamison","year":"2006"},{"key":"10.1002\/14651858.CD006612.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCULATIONAHA.108.190186","article-title":"The impact of prevention on reducing the burden of cardiovascular disease","volume":"118","author":"Kahn","year":"2008","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD006612.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jacc.2006.04.086","article-title":"Homocysteine hypothesis for atherothrombotic cardiovascular disease: Not validated","volume":"48","author":"Kaul","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0002-8223(97)00044-8","article-title":"Folate nutrition and older adults: challenges and opportunities","volume":"97","author":"Koehler","year":"1997","journal-title":"Journal of the American Dietetic Association"},{"key":"10.1002\/14651858.CD006612.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00005344-199500252-00003","article-title":"Cytokines regulate vascular functions related to stability of the atherosclerotic plaque","volume":"25 (Suppl 2)","author":"Libby","year":"1995","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMe068060","article-title":"Homocysteine Trials - Clear Outcomes for Complex Reasons","volume":"354","author":"Loscalzo","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD006612.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0828-282X(07)70814-0","article-title":"Homocysteine lowering and cardiovascular disease risk: lost in translation","volume":"23","author":"Marcus","year":"2007","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/oxfordjournals.aje.a008798","article-title":"Lowered risks of hypertension and cerebrovascular disease after vitamin\/mineral supplementation: the Linxian Nutrition Intervention Trial","volume":"143","author":"Mark","year":"1996","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cll.2006.06.008","article-title":"Homocysteine","volume":"26","author":"Maron","year":"2006","journal-title":"Clinics in Laboratory Medicine"},{"key":"10.1002\/14651858.CD006612.pub2-BIB76|cit76","first-page":"590","article-title":"Steps to control the burden of cardiovascular disease in the Indian Subcontinent","volume":"125","author":"Math","year":"2007","journal-title":"The Indian Journal of Medical Research"},{"key":"10.1002\/14651858.CD006612.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1515\/CCLM.2005.172","article-title":"Hyperhomocysteinemia and arteriosclerosis: historical perspectives","volume":"43","author":"McCully","year":"2005","journal-title":"Clinical Chemistry & Laboratory Medicine"},{"key":"10.1002\/14651858.CD006612.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1017\/S0029665108007076","article-title":"Homocysteine, B-vitamins and CVD","volume":"67","author":"McNulty","year":"2008","journal-title":"The Proceeding of the Nutrition Society"},{"key":"10.1002\/14651858.CD006612.pub2-BIB79|cit79","first-page":"229","article-title":"The effect of folate fortified bread on homocysteine, folate and vitamin B12 status among hyperhomocysteinemic subjects: Tehran homocysteine study","volume":"7","author":"Mirarefin","year":"2007","journal-title":"Iranian Journal of Diabetes and Lipid Disorders"},{"key":"10.1002\/14651858.CD006612.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1258\/acb.2008.008053","article-title":"Plasma total homocysteine: instigator or indicator of cardiovascular disease?","volume":"45 (Pt 4)","author":"Moat","year":"2008","journal-title":"Annals of Clinical Biochemistry"},{"key":"10.1002\/14651858.CD006612.pub2-BIB81|cit81","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.amjcard.2006.08.057","article-title":"Effect of folic acid on endothelial function following acute myocardial infarction","volume":"99","author":"Moens","year":"2007","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB82|cit82","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.ATV.20.7.1704","article-title":"Homocysteine and its disulfide derivatives: a suggested consensus terminology","volume":"20","author":"Mudd","year":"2000","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1373\/clinchem.2008.115899","article-title":"National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease","volume":"55","author":"Myers","year":"2009","journal-title":"Clinical Chemistry"},{"key":"10.1002\/14651858.CD006612.pub2-BIB84|cit84","article-title":"Diabetes: the pandemic and potential solutions","volume-title":"Disease control priorities in developing countries","author":"Narayan","year":"2006"},{"issue":"2 Art. No.: CD0","key":"10.1002\/14651858.CD006612.pub2-BIB85|cit85","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004683.pub3","article-title":"Interventions for lowering plasma homocysteine levels in dialysis patients","author":"Nigwekar","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006612.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-145-5-200609050-00136","article-title":"NIH State-of-the-Science Conference Statement on Multivitamin\/Mineral Supplements and Chronic Disease Prevention","volume":"145","year":"2006","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD006612.pub2-BIB87|cit87","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","article-title":"Plasma homocysteine levels and mortality in patients with coronary artery disease","volume":"337","author":"Nyg\u00e5rd","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006612.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.febslet.2009.03.038","article-title":"Homocysteine and lipids: S-adenosyl methionine as a key intermediate","volume":"583","author":"Obeid","year":"2009","journal-title":"FEBS Letters"},{"key":"10.1002\/14651858.CD006612.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1515\/CCLM.2007.021","article-title":"The effect of homocysteine reduction by B-vitamin supplementation on inflammatory markers","volume":"45","author":"Peeters","year":"2007","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"10.1002\/14651858.CD006612.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00726-006-0432-9","article-title":"Mechanisms of homocysteine toxicity in humans","volume":"32","author":"Per\u0142a-Kaj\u00e1n","year":"2007","journal-title":"Amino Acids"},{"key":"10.1002\/14651858.CD006612.pub2-BIB91|cit91","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1161\/01.CIR.103.22.2717","article-title":"Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease","volume":"103","author":"Poddar","year":"2001","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD006612.pub2-BIB92|cit92","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2261-8-24","article-title":"The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis","volume":"8","author":"Potter","year":"2008","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1002\/14651858.CD006612.pub2-BIB93|cit93","first-page":"27","article-title":"Homocysteine and cardiovascular disease: should we treat?","volume":"29","author":"Potter","year":"2008","journal-title":"The Clinical Biochemist. Reviews"},{"key":"10.1002\/14651858.CD006612.pub2-BIB94|cit94","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF01616850","article-title":"Homocysteine, a risk factor for cardiovascular disease","volume":"8","author":"Prasad","year":"1999","journal-title":"International Journal of Angiology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB95|cit95","first-page":"275","article-title":"Biochemistry of homocysteine in health and diseases","volume":"43","author":"Ramakrishnan","year":"2006","journal-title":"Indian Journal of Biochemistry & Biophysics"},{"key":"10.1002\/14651858.CD006612.pub2-BIB96|cit96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07315724.2003.10719270","article-title":"Folate: a key to optimizing health and reducing disease risk in the elderly","volume":"22","author":"Rampersaud","year":"2003","journal-title":"Journal of the American College of Nutrition"},{"key":"10.1002\/14651858.CD006612.pub2-BIB97|cit97","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.med.49.1.31","article-title":"Homocysteine and cardiovascular disease","volume":"49","author":"Refsum","year":"1998","journal-title":"Annual Review of Medicine"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD006612.pub2-BIB98|cit98","doi-asserted-by":"crossref","first-page":"1731S","DOI":"10.1093\/jn\/136.6.1731S","article-title":"The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease","volume":"136","author":"Refsum","year":"2006","journal-title":"Journal of Nutrition"},{"key":"10.1002\/14651858.CD006612.pub2-BIB99|cit99","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.ATV.0000150651.85907.69","article-title":"Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia","volume":"25","author":"Riksen","year":"2005","journal-title":"Arteriosclerosis, Thrombosis & Vascular Biology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB100|cit100","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1503\/cmaj.045055","article-title":"Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain product products","volume":"172","author":"Robertson","year":"2005","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD006612.pub2-BIB101|cit101","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.CIR.97.5.437","article-title":"Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group","volume":"97","author":"Robinson","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD006612.pub2-BIB102|cit102","article-title":"The growing burden of risk from high blood pressure, cholesterol, and bodyweight","volume-title":"Disease control priorities in developing countries","author":"Rodgers","year":"2006"},{"key":"10.1002\/14651858.CD006612.pub2-BIB103|cit103","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-510X(02)00210-1","article-title":"Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke : effect of combined therapy with folic acid and mecobalamine","volume":"202","author":"Sato","year":"2002","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD006612.pub2-BIB104|cit104","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","article-title":"Vitamin status and intake as primary determinants of homocysteinemia in an elderly population","volume":"270","author":"Selhub","year":"1993","journal-title":"JAMA"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD006612.pub2-BIB105|cit105","doi-asserted-by":"crossref","first-page":"1726S","DOI":"10.1093\/jn\/136.6.1726S","article-title":"The many facets of hyperhomocysteinemia: studies from the Framingham cohorts","volume":"136","author":"Selhub","year":"2006","journal-title":"Journal of Nutrition"},{"key":"10.1002\/14651858.CD006612.pub2-BIB106|cit106","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/15648265080292S116","article-title":"Public health significance of elevated homocysteine","volume":"29 (Suppl 2)","author":"Shelhub","year":"2008","journal-title":"Food and Nutrition Bulletin"},{"key":"10.1002\/14651858.CD006612.pub2-BIB107|cit107","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.atherosclerosis.2007.09.009","article-title":"Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels","volume":"198","author":"Sofi","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD006612.pub2-BIB108|cit108","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/01.STR.0000185929.38534.f3","article-title":"Vitamin Intervention For Stroke Prevention trial: an efficacy analysis","volume":"36","author":"Spence","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD006612.pub2-BIB109|cit109","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1474-4422(07)70219-3","article-title":"Homocysteine-lowering therapy: a role in stroke prevention?","volume":"6","author":"Spence","year":"2007","journal-title":"The Lancet Neurology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB110|cit110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ahj.2004.02.004","article-title":"Homocysteine and cardiovascular disease: biological mechanism, observational epidemiology, and the need for randomised trials","volume":"148","author":"Splaver","year":"2004","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD006612.pub2-BIB111|cit111","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","article-title":"prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians","volume":"268","author":"Stampfer","year":"1992","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub2-BIB112|cit112","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.nut.2005.01.011","article-title":"Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression","volume":"21","author":"Su","year":"2005","journal-title":"Nutrition"},{"key":"10.1002\/14651858.CD006612.pub2-BIB113|cit113","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000099068","article-title":"Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow","volume":"107","author":"Tanriverdi","year":"2007","journal-title":"Cardiology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB114|cit114","article-title":"Plasma homocysteine and cardiovascular disease","volume-title":"Atherosclerotic cardiovascular disease hemostasis and endothelial function","author":"Ueland","year":"1992"},{"key":"10.1002\/14651858.CD006612.pub2-BIB115|cit115","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcn\/72.2.324","article-title":"The controversy over homocysteine and cardiovascular risk","volume":"72","author":"Ueland","year":"2000","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD006612.pub2-BIB116|cit116","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1373\/clinchem.2007.085480","article-title":"Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power","volume":"53","author":"Ueland","year":"2007","journal-title":"Clinical Chemistry"},{"key":"10.1002\/14651858.CD006612.pub2-BIB117|cit117","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1158\/1055-9965.EPI-152CO","article-title":"Folate supplementation: too much of a good thing?","volume":"15","author":"Ulrich","year":"2006","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1002\/14651858.CD006612.pub2-BIB118|cit118","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1160\/TH06-04-0228","article-title":"Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia","volume":"96","author":"Undas","year":"2006","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD006612.pub2-BIB119|cit119","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1177\/0091270007303767","article-title":"Mesna as a nonvitamin intervention to lower plasma total homocysteine concentration: implications for assessment of the homocysteine theory of atherosclerosis","volume":"47","author":"Urquhart","year":"2007","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB120|cit120","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/hq0102.102190","article-title":"Folates and cardiovascular disease","volume":"22","author":"Verhaar","year":"2002","journal-title":"Arteriosclerosis, Thrombosis & Vascular Biology"},{"key":"10.1002\/14651858.CD006612.pub2-BIB121|cit121","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1542-4758.2007.00171.x","article-title":"Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events","volume":"11","author":"Vianna","year":"2007","journal-title":"Hemodialysis International"},{"key":"10.1002\/14651858.CD006612.pub2-BIB122|cit122","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0140-6736(03)13637-9","article-title":"Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials","volume":"361","author":"Vivekananthan","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006612.pub2-BIB123|cit123","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006612.pub2-BIB124|cit124","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ddmec.2005.05.029","article-title":"Mechanisms in homocysteine-induced vascular disease","volume":"2","author":"Wang","year":"2005","journal-title":"Drug Discovery Today: Disease Mechanisms"},{"key":"10.1002\/14651858.CD006612.pub2-BIB125|cit125","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(07)60854-X","article-title":"Efficacy of folic acid supplementation in stroke prevention: a meta-analysis","volume":"369","author":"Wang","year":"2007","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD006612.pub2-BIB126|cit126","volume-title":"The world health report: reducing risks, promoting healthy life. Available at http:\/\/www.who.int\/whr\/2002\/en\/whr02_en.pdf [accessed 01 01 2007]","year":"2002"},{"key":"10.1002\/14651858.CD006612.pub2-BIB127|cit127","article-title":"Prevention of chronic disease by means of diet and lifestyle changes","volume-title":"Disease control priorities in developing countries","author":"Willett","year":"2006"},{"key":"10.1002\/14651858.CD006612.pub2-BIB128|cit128","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ajcn\/88.2.348","article-title":"Bread cofortified with folic acid and vitamin B-12 improves the folate and vitamin B-12 status of healthy older people: a randomized controlled trial","volume":"88","author":"Winkels","year":"2008","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD006612.pub2-BIB129|cit129","article-title":"Technical aspects of food fortification","volume-title":"Food and Nutrition Bulletin","volume":"19","author":"Wirakartakusumah","year":"1998"},{"issue":"7644","key":"10.1002\/14651858.CD006612.pub2-BIB130|cit130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006612.pub2-BIB131|cit131","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/oxfordjournals.eurheartj.a061905","article-title":"Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials","volume":"6","author":"Yusuf","year":"1985","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD006612.pub2-BIB132|cit132","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/biof.17","article-title":"Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms","volume":"35","author":"Zhou","year":"2009","journal-title":"Biofactors"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006612.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:01:46Z","timestamp":1628532106000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006612.pub2"}},"subtitle":[],"editor":[{"given":"Arturo J","family":"Mart\u00ed-Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,7]]},"references-count":132,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006612.pub2","relation":{},"subject":[],"published":{"date-parts":[[2009,10,7]]}}}